NCT00193180 - Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

January 31, 2009

Conditions

Breast Cancer

Interventions

DRUG

Imatinib

DRUG

Docetaxel

Trial Locations (6)

Northeast Georgia Medical Center, Gainesville

Tennessee Oncology, Nashville

Consultants in Blood Disorders and Cancer, Louisville

Oncology Hematology Care, Cincinnati

Methodist Cancer Center, Omaha

Baton Rouge General Medical Center, Baton Rouge